Experimental pancreatic cancer pill doubles survival, boosts quality of life
An experimental pancreatic cancer pill, daraxonrasib, has shown to double survival rates and improve quality of life compared to chemotherapy. Read more at straitstimes.com. Read more at straitstimes.com.
31 May 13:13 · The Straits Times